OSE_1303_part2_Layout 1 2/7/13 4:27 PM Page 69
O P H T H A L M O L O G Y
Cataract | Refractive | Glaucoma
of a patient's eye — a detail that reportedly
can affect the shape of the eye during treatment, and subsequently the incisions made.
There's no convenient way to demonstrate
and trial this technology on human patients in
Your process.
Your patients.
Our specialty.
conference exhibit halls or even in your own
surgical suites. And it's difficult to ascertain
whether the technology will provide you with
improved outcomes unless you actually testdrive it. So how should you choose?
As the earliest of early adopters (in 2011,
they were the fifth practice in the world to
purchase a laser system), Dr. Berdahl's center's options were limited: only the LenSx
platform had at that point earned FDA clear-
Call to learn more about
Sightpath Medical's
Equipment & Services.
ance. Plus, a senior partner in the practice
888.975.5526
had played a role in the clinical testing during
its development. "It was the only choice," he
says, "but we'd still choose it."
Even if you're not an early adopter and didn't have a hand in building the technology, his
reason why may still resonate: manufacturer
Visit SightpathMedical.com/OS
for more information.
reputation. "We're a brand-agnostic practice,"
he says. "We use all kinds of lenses and instruF E B R U A R Y 2013 | O U T PAT I E N T S U R G E R Y M A G A Z I N E O N L I N E
6 9
